The I148M PNPLA3 variant mitigates Niacin beneficial effects: How the genetic screening in NAFLD patients gains value

被引：0

作者：

Paolini, E. ^{[1
,2
]}

Longo, M. ^{[1
,3
]}

Meroni, M. ^{[1
,4
]}

Malaspina, G. ^{[1
]}

De Caro, E. R. ^{[1
]}

Cespiati, A. ^{[1
,4
]}

Lombardi, R. ^{[1
,4
]}

Fracanzani, A. L. ^{[1
,4
]}

Dongiovanni, P. ^{[1
]}

机构：

[1] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy

[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Gen Med & Metab Dis, Milan, Italy

[3] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy

[4] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Milan, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2021年 / 53卷

关键词：

D O I：

10.1016/j.dld.2020.12.074

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P-35

引用

页码：S29 / S30

页数：4

共 50 条

[1] THE I148M PNPLA3 VARIANT MITIGATES NIACIN BENEFICIAL EFFECTS: HOW THE GENETIC SCREENING IN NAFLD PATIENTS GAINS VALUE
Paolini, Erika
Longo, Miriam
Meroni, Marica
Cespiati, Annalisa
Lombardi, Rosa
Fracanzani, Anna Ludovica
Dongiovanni, Paola
HEPATOLOGY, 2021, 74 : 1126A - 1126A
[2] The I148M PNPLA3 variant mitigates Niacin beneficial effects: how the genetic screening in Non-alcoholic Fatty Liver Disease (NAFLD) patients gains value
Paolini, Erika
Longo, Miriam
Meroni, Marica
Malaspina, Gemma
De Caro, Emilia
Cespiati, Annalisa
Lombardi, Rosa
Fracanzani, Anna Ludovica
Dongiovanni, Paola
JOURNAL OF HEPATOLOGY, 2021, 75 : S601 - S602
[3] The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value
Paolini, Erika
Longo, Miriam
Meroni, Marica
Tria, Giada
Cespiati, Annalisa
Lombardi, Rosa
Badiali, Sara
Maggioni, Marco
Fracanzani, Anna Ludovica
Dongiovanni, Paola
FRONTIERS IN NUTRITION, 2023, 10
[4] The I48M PNPLA3 variant mitigates Niacin beneficial effects: how the genetic screening in non-alcoholic fatty liver disease (NAFLD) patients gains value
Paolini, Erika
Longo, Miriam
Meroni, Marica
Piciotti, Roberto
Cespiati, Annalisa
Lombardi, Rosa
Fracanzani, Anna Ludovica
Dongiovanni, Paola
JOURNAL OF HEPATOLOGY, 2022, 77 : S682 - S682
[5] Genetic variant I148M in PNPLA3 is associated with acoustic radiation force impulse imaging in patients with NAFLD
Yoshioka, Kentaro
Shimazaki, Hiroaki
Kawabe, Naoto
Harata, Masao
Nitta, Yoshifumi
Murao, Michihito
Nakano, Takuji
Arima, Yuko
Kan, Toshiki
Ohki, Masashi
Nakaoka, Kazunori
Yuka, Takagawa
Nishikawa, Toru
Osakabe, Keisuke
Ichino, Naohiro
Hashimoto, Senju
HEPATOLOGY, 2013, 58 : 480A - 480A
[6] Hepatocellular carcinoma, obesity and the PNPLA3 I148M genetic variant
Nature Reviews Gastroenterology & Hepatology, 2012, 9 (8) : 426 - 426
[7] Interleukin-32 as a novel NAFLD biomarker in PNPLA3 I148M variant carriers
Baselli, Guido Alessandro
Dongiovanni, Paola
Rametta, Raffaela
Meroni, Marica
Pelusi, Serena
Maggioni, Marco
Badiali, Sara
Pingitore, Piero
Montalcini, Tiziana
Rossi, Giorgio
Prati, Daniele
Fargion, Silvia
Mancina, Rosellina
Romeo, Stefano
Valenti, Luca
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E755 - E755
[8] PNPLA3 I148M variant and hepatocellular carcinoma: A common genetic variant for a rare disease
Valenti, Luca
Dongiovanni, Paola
Corradini, Stefano Ginanni
Burza, Maria Antonella
Romeo, Stefano
DIGESTIVE AND LIVER DISEASE, 2013, 45 (08) : 619 - 624
[9] The PNPLA3 I148M variant initiates metabolic reprogramming in macrophages
Dixon, Emmanuel Dauda
Claudel, Thierry
Genger, Jakob-Wendelin
Zhu, Ci
Stadlmayr, Sarah
Paolini, Erika
Nardo, Alexander D.
Mlitz, Veronika
Fuchs, Claudia
Bergthaler, Andreas
Radtke, Christine
Dongiovanni, Paola
Ellmeier, Wilfried
Trauner, Michael
JOURNAL OF HEPATOLOGY, 2023, 78 : S739 - S740
[10] THE PNPLA3 I148M VARIANT INITIATES METABOLIC REPROGRAMMING IN MACROPHAGES
Dixon, Emmanuel
Claudel, Thierry
Genger, Jakob-Wendelin
Zhu, Ci
Stadlmayr, Sarah
Paolini, Erika
Nardo, Alexander
Mlitz, Veronika
Fuchs, Claudia
Bergthaler, Andreas
Dongiovanni, Paola
Ellmeier, Wilfried
Trauner, Michael
HEPATOLOGY, 2024, 80 : S1990 - S1991

← 1 2 3 4 5 →